EFFECTOR Therapeutics Insiders
EFTRWDelisted Stock | USD 0 0.00 0.00% |
EFFECTOR Therapeutics employs about 14 people. The company is managed by 9 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 1.56 employees per reported executive. Recap of EFFECTOR Therapeutics' management performance can provide insight into the venture performance.
Stephen Worland CEO President CEO |
EFFECTOR |
EFFECTOR Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.8333) % which means that it has lost $0.8333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (9.4656) %, meaning that it generated substantial loss on money invested by shareholders. EFFECTOR Therapeutics' management efficiency ratios could be used to measure how well EFFECTOR Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.EFFECTOR Therapeutics Workforce Comparison
EFFECTOR Therapeutics is rated # 5 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 346. EFFECTOR Therapeutics holds roughly 14.0 in number of employees claiming about 4% of equities under Health Care industry.
EFFECTOR Therapeutics Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EFFECTOR Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on EFFECTOR Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EFFECTOR Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Presidio Management Group X Llc over six months ago Disposition of 799 shares by Presidio Management Group X Llc of EFFECTOR Therapeutics at 6.695 subject to Rule 16b-3 | ||
Byrnes Michael over six months ago Acquisition by Byrnes Michael of 4524 shares of EFFECTOR Therapeutics at 0.4973 subject to Rule 16b-3 | ||
Ehrlich Christopher B over six months ago Acquisition by Ehrlich Christopher B of 18867 shares of EFFECTOR Therapeutics at 0.55 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Disposition of 33799 shares by Stephen Worland of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 | ||
Stephen Worland over six months ago Acquisition by Stephen Worland of 33799 shares of EFFECTOR Therapeutics at 0.52 subject to Rule 16b-3 |
EFFECTOR Therapeutics Notable Stakeholders
An EFFECTOR Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EFFECTOR Therapeutics often face trade-offs trying to please all of them. EFFECTOR Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EFFECTOR Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephen Worland | President CEO | Profile | |
Siegfried Reich | CoFounder Advisor | Profile | |
Mayank MD | Chief Officer | Profile | |
Michael MBA | Chief Officer | Profile | |
Alana MBA | Chief Officer | Profile | |
Premal MD | Chief Officer | Profile | |
Davide Ruggero | CoFounder Board | Profile | |
Douglas MD | Chief Officer | Profile | |
Kevan Shokat | CoFounder Board | Profile |
About EFFECTOR Therapeutics Management Performance
The success or failure of an entity such as EFFECTOR Therapeutics often depends on how effective the management is. EFFECTOR Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EFFECTOR management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EFFECTOR management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in EFFECTOR Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EFFECTOR Therapeutics. Check EFFECTOR Therapeutics' Beneish M Score to see the likelihood of EFFECTOR Therapeutics' management manipulating its earnings.
EFFECTOR Therapeutics Workforce Analysis
Traditionally, organizations such as EFFECTOR Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EFFECTOR Therapeutics within its industry.EFFECTOR Therapeutics Manpower Efficiency
Return on EFFECTOR Therapeutics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 2.6M | |
Net Loss Per Executive | 4M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in EFFECTOR Pink Sheet
If you are still planning to invest in EFFECTOR Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EFFECTOR Therapeutics' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |